Biocompatible lipid nanovehicles for preventive and therapeutic vaccine development
Coordination Chemistry Reviews · 2025-09 · 538 · 216718
DOI: 10.1016/j.ccr.2025.216718 ↗Kurz gefasst
Fachartikel in der Zeitschrift Coordination Chemistry Reviews, 2025-09. Verfasst von Yaru Jia und 7 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 379 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Natural Science Foundation of China-Guangdong Joint Fund, Natural Science Foundation of Hebei Province.
Abstract (Originalsprache)
Vaccines are widely recognized as one of the most economical and time-efficient medical interventions. Lipid-based nanovehicles have emerged as transformative platforms in clinical applications due to their unique biocompatibility , precision-designed delivery efficacy, and scale-up accessibility for mass production. These nanovaccines are actively being developed for the prevention of infectious diseases and the immunotherapy for conditions such as cancers. This review provides a comprehensive overview of lipid-based nanovaccines, covering their material sources, classification of delivery vehicles, and unique advantages. Lipid-based nanovehicles are highlighted for their ability to enhance antigen stability, improve immune response precision, and enable diverse administration routes, including intramuscular, subcutaneous, oral, and inhalation methods. Additionally, lipid-based nanovaccines in the aspect of clinical application are discussed, emphasizing their potential in the optimization of immune responses, reducing adverse effects , and overcoming physiological barriers. The development of lipid-based nanovaccines faces some challenges, including balancing safety, efficacy, and production scalability. Therefore, further strategies, such as targeted delivery, intelligent controlled release, and adjuvant incorporation, crucially contribute to the advancement of preventive and therapeutic vaccines.
Förderung
- National Natural Science Foundation of China
- National Natural Science Foundation of China-Guangdong Joint Fund
- Natural Science Foundation of Hebei Province
- National Key Research and Development Program of China
- Ministry of Science and Technology of the People's Republic of China
- Office of the Civil Service Commission
Zitieren
APA
Jia, Y., Zhou, Z., Jiramonai, L., Chen, J., Hua, Q., Zhu, M., Zhang, J., & Liang, X. (2025). Biocompatible lipid nanovehicles for preventive and therapeutic vaccine development. Coordination Chemistry Reviews, 538, 216718. https://doi.org/10.1016/j.ccr.2025.216718
Vancouver
Jia Y, Zhou Z, Jiramonai L, Chen J, Hua Q, Zhu M, et al. Biocompatible lipid nanovehicles for preventive and therapeutic vaccine development. Coordination Chemistry Reviews. 2025;538:216718. doi:10.1016/j.ccr.2025.216718
BibTeX
@article{Jia2025,
author = {Jia, Yaru and Zhou, Ziran and Jiramonai, Luksika and Chen, Jianxin and Hua, Qian and Zhu, Mengliang and Zhang, Jinchao and Liang, Xing-Jie},
title = {Biocompatible lipid nanovehicles for preventive and therapeutic vaccine development},
journal = {Coordination Chemistry Reviews},
year = {2025},
volume = {538},
pages = {216718},
doi = {10.1016/j.ccr.2025.216718}
}
EUVIMED